HCSGD entry for PRELP
1. General information
Official gene symbol | PRELP |
---|---|
Entrez ID | 5549 |
Gene full name | proline/arginine-rich end leucine-rich repeat protein |
Other gene symbols | MST161 MSTP161 SLRR2A |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001501 | Skeletal system development | TAS | biological_process |
GO:0005201 | Extracellular matrix structural constituent | IEA | molecular_function |
GO:0005576 | Extracellular region | TAS | cellular_component |
GO:0005578 | Proteinaceous extracellular matrix | IEA | cellular_component |
GO:0005796 | Golgi lumen | TAS | cellular_component |
GO:0005975 | Carbohydrate metabolic process | TAS | biological_process |
GO:0007569 | Cell aging | IEA | biological_process |
GO:0008201 | Heparin binding | IEA | molecular_function |
GO:0018146 | Keratan sulfate biosynthetic process | TAS | biological_process |
GO:0030203 | Glycosaminoglycan metabolic process | TAS | biological_process |
GO:0031012 | Extracellular matrix | IDA ISS | cellular_component |
GO:0042339 | Keratan sulfate metabolic process | TAS | biological_process |
GO:0042340 | Keratan sulfate catabolic process | TAS | biological_process |
GO:0043202 | Lysosomal lumen | TAS | cellular_component |
GO:0044281 | Small molecule metabolic process | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0052281524 | 0.9182744653 | 0.1888559508 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0338492624 |
GSE13712_SHEAR | Up | 0.1016951742 |
GSE13712_STATIC | Up | 0.0627801585 |
GSE19018 | Down | -0.0370111329 |
GSE19899_A1 | Up | 0.1625169098 |
GSE19899_A2 | Up | 0.1960461685 |
PubMed_21979375_A1 | Down | -0.0060078197 |
PubMed_21979375_A2 | Up | 0.0869235894 |
GSE35957 | Down | -0.8849612256 |
GSE36640 | Down | -0.0170850498 |
GSE54402 | Down | -0.1811163330 |
GSE9593 | Down | -0.1940188932 |
GSE43922 | Up | 0.0014494963 |
GSE24585 | Up | 0.0627462861 |
GSE37065 | Up | 1.3862373930 |
GSE28863_A1 | Up | 1.2569853505 |
GSE28863_A2 | Up | 1.6763015945 |
GSE28863_A3 | Up | 1.2476689915 |
GSE28863_A4 | Up | 0.2980841996 |
GSE48662 | Up | 0.9076645957 |